Modern Treatment Modalities and Duration of Treatment for Venous Thromboembolism
ContributorsRobert-Ebadi, Helia; Righini, Marc Philip
Published inTherapeutische Umschau, vol. 73, no. 10, p. 618-625
Publication date2016
Keywords
- Administration
- Oral
- Anticoagulants/adverse effects/pharmacokinetics/therapeutic use
- Clinical Trials
- Phase III as Topic
- Dabigatran/adverse effects/pharmacokinetics/therapeutic use
- Dose-Response Relationship
- Drug
- Drug Administration Schedule
- Hemorrhage/blood/chemically induced
- Humans
- International Normalized Ratio
- Pulmonary Embolism/blood/drug therapy
- Pyrazoles/adverse effects/pharmacokinetics/therapeutic use
- Pyridines/adverse effects/pharmacokinetics/therapeutic use
- Pyridones/adverse effects/pharmacokinetics/therapeutic use
- Rivaroxaban/adverse effects/pharmacokinetics/therapeutic use
- Thiazoles/adverse effects/pharmacokinetics/therapeutic use
- Venous Thromboembolism/blood/drug therapy
- Vitamin K/antagonists & inhibitors
Affiliation entities
Research groups
Citation (ISO format)
ROBERT-EBADI, Helia, RIGHINI, Marc Philip. Modern Treatment Modalities and Duration of Treatment for Venous Thromboembolism. In: Therapeutische Umschau, 2016, vol. 73, n° 10, p. 618–625. doi: 10.1024/0040-5930/a000833
Identifiers
- PID : unige:99390
- DOI : 10.1024/0040-5930/a000833
- PMID : 28045360
Journal ISSN0040-5930
